Radiation Dermatitis Market Size, Share, Analysis, Industry Report, Trends, competitive Insights and Forecast 2020-2030

Radiation Dermatitis Market: Introduction
According to the report, the global radiation dermatitis market was valued at ~US$ 400 Mn in 2019 and is projected to expand at a CAGR of ~5% from 2020 to 2030. The International Agency for Research on Cancer (IARC) states that the number of new cancer cases is likely to rise to 19.3 million, with 10 million cancer deaths in 2020. This indicates one in 5 people develop cancer during their lifetime, and one in 8 men and one in 11 women succumb to the disease. According to statistics presented by the American Society for Radiation Oncology, nearly 95% of patients receiving radiation therapy suffer from some degree of radiation dermatitis, whereas 85% of the total patient base experience severe to moderate radiation dermatitis that requires intensive treatment. This is expected to propel the global radiation dermatitis market.

Request Sample: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=81522

Asia Pacific dominated the global radiation dermatitis market in 2019 and the trend is anticipated to continue during the forecast period. The rise in population suffering from cancer in Asia Pacific has increased the number of patients opting for radiation therapy. Hence, the usage of radiation dermatitis treatment products is expected to increase during the forecast period. Asia Pacific is likely to be a highly lucrative market for radiation dermatitis treatment from 2020 to 2030. The market in the region is projected to expand at a high CAGR during the forecast period.
Rise in Prevalence of Cancer to Drive Market
According to the WHO, cancer is the second leading cause of death globally, accounting for an estimated 9.6 million deaths, or one in six deaths, in 2018. Lung, prostate, colorectal, stomach, and liver are the most common types of cancer in men, while breast, colorectal, lung, cervical, and thyroid cancer are the most common among women. The rate of certain types of cancer such as breast and head & neck is projected to increase in the near future. This can be attributed to faulty lifestyle factors such as obesity for breast cancer and smoking for head & neck cancers. Moreover, cancers mentioned above are treated with radiation at site. Hence, patients suffering from these cancers are more likely to develop radiation-induced dermatitis. Therefore, the overall rise in cancer cases coupled with a surge in specific cancers due to faulty lifestyle is likely to propel the global radiation dermatitis market.

Enquiry Before Buying: https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=81522

Topical Agents to Dominate Global Market
In terms of product, the global radiation dermatitis market has been classified into oral medication, topical, and dressings. The topical segment dominated the global radiation dermatitis market in 2019 and the trend is projected to continue during the forecast period. The growth of the segment can be attributed to the fact that topical agents are the most prescribed products in the radiation dermatitis treatment market, especially hydrophilic creams and corticosteroids. Hydrophilic creams are extensively used across the globe, as these provide hydration and soothing relief from itching, and other symptoms of radiation dermatitis.

Request Brochure: https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=81522

Retail Pharmacies to be Major Distribution Channel
Based on distribution channel, the global radiation dermatitis market has been categorized into hospital pharmacies, retail pharmacies, and online pharmacies. The retail pharmacies segment dominated the global radiation dermatitis market and the trend is anticipated to continue during the forecast period. Radiation dermatitis can develop either during or even several months after radiation therapy. Hence, a retail pharmacy is likely to be driven by patients who are referred to purchase particular products by peer recommendation. Additionally, it is driven by proximity to local area and familiarity of use by loyal customers.

Request for covid19 Impact Analysis: https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=81522

Competition Landscape
Key players in the global radiation dermatitis market include 3M Company, Mölnlycke Health Care AB, Smith & Nephew plc, Integra Lifesciences Holdings Corporation, Intermed S.A., ConvaTec Group plc, and BMG PHARMA S.p.A.

More Trending Reports by Transparency Market Research:

https://www.prnewswire.com/news-releases/ultrasound-devices-market-to-gain-business-prospects-due-to-rise-in-prevalence-of-stroke-cancer-and-heart-disease-says-tmr-301489966.html

https://www.prnewswire.com/news-releases/north-america-lactate-meters-market-to-reach-us-115-2-mn-by-2031--says-tmr-study-301474149.html

Contact
Mr. Rohit Bhisey
Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: https://www.transparencymarketresearch.com/

About Us
Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.
Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through ad hoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.
TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.

This release was published on openPR.